Announcements

Latest announcements

Directors’ appointments/resignation

Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has appointed Jonathan Peter Wearing as an independent non-executive director and Angus Jeremy Kerr as a non-executive director of the Company.

Sativa signs IP agreement with Canadian-based Veritas Pharma Inc.

Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has signed an IP sharing agreement with Canadian-based emerging global pharmaceutical company Veritas Pharma Inc. (“Veritas” or “Veritas Pharma”) in which the Company invested C$ 0.2 million cash in May 2018.

Dealing Arrangements

The Board of Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, is aware of the exceptional and growing demand amongst investors to own shares in the Company.

Sativa agrees to the 100% purchase of PhytoVista Laboratories

Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has agreed to purchase, for £435,000, 100 per cent of PhytoVista Laboratories (“PhytoVista”), a UK-based laboratory that tests CBD oils and hemp products. The Company will pay £235,000 in cash and £200,000 worth of shares at £0.04 pence per share.

Share Placing completed to Miton Asset Management

Sativa Investments PLC (NEX:SATI), the UK’s first medicinal cannabis investment vehicle, announces that the share Placing of 12,500,000 new Ordinary Shares at a subscription price of 4 pence per share announced on Wednesday 27 June, raising £500,000 before expenses, has been successfully completed with LF Miton UK Smaller Companies Fund.

Sativa Share Placing

Sativa Investments PLC (NEX:SATI), the UK’s first medicinal cannabis investment vehicle, announces that it has raised £500,000 before expenses by way of a placing of 12,500,000 new Ordinary Shares at 4 pence per share to a single institutional investor.

Orderly Market Agreement – Director’s Dealing

SSativa Investments PLC (NEX:SATI), the UK’s first medicinal cannabis investment vehicle, announces that today, 25 June 2018, Mark Blower, an executive director of the Company, sold 1,000,000 ordinary shares of £0.0025 at a price of £0.04 per share and Noel Lyons, a non-executive Director of the Company, sold 500,000 ordinary shares of £0.0025 each in the Company at a price of £0.0425, pursuant to an orderly market agreement to satisfy market demand.

Sativa Share Price Movement

The Board of Sativa Investments PLC (NEX:SATI), the UK’s only medicinal cannabis investment vehicle, notes the recent rise in the Company’s share price.

Sativa passes resolution at General Meeting to broaden investment policy

Sativa Investments PLC (NEX:SATI), the UK’s only medicinal cannabis investment vehicle, announces that all Resolutions were passed by the requisite majority at the Company’s General Meeting today, including Resolutions to broaden its investment strategy beyond Canada, the authority to allot shares, and the disapplication of pre-emption rights.

Sativa agrees purchase of 100% of CBD product provider George Botanicals

Sativa Investments PLC (NEX:SATI), the UK’s only medicinal cannabis investment vehicle, has agreed to purchase, for £415,000, 100 per cent of George Botanicals Ltd, a UK-based manufacturer, wholesaler and distributor of wellness CBD products, following the Memorandum of Understanding announced by Sativa on Tuesday 17 April, 2018.